Pharmacological Management, Revascularization Techniques, and Preventative Strategies in the Global Angina Market
The Angina Market addresses the diagnosis and management of chest pain resulting from myocardial ischemia, most commonly caused by coronary artery disease (CAD). As a major segment of the broader cardiovascular therapeutics landscape, market growth is driven by the high and rising global prevalence of CAD, fueled by lifestyle risk factors such as hypertension, diabetes, obesity, and smoking. Current treatment strategies involve a combination of lifestyle modifications, anti-ischemic drugs (nitrates, beta-blockers, calcium channel blockers), and revascularization procedures, including Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG). The introduction of novel anti-anginal drugs with different mechanisms of action aims to improve symptomatic control, especially in patients refractory to conventional therapies. For group discussion, a significant focus must be placed on public health initiatives for primary prevention, as managing risk factors before they lead to advanced CAD remains…